Home » Topics » BioWorld Science

BioWorld Science
RSS

Gensia pursues formation of Metabasis as separate company and announces Sankyo investment

Dec. 22, 1997

Isolation, structural elucidation and preliminary biological evaluation of new XOD inhibitor

Dec. 22, 1997

Novel nicotinic ligand discovered by British university researchers

Dec. 22, 1997

New antiviral agent for flu disclosed in patent literature

Dec. 22, 1997

Pharmacological characterization of LY-344864, a selective 5-HT1F receptor agonist

Dec. 22, 1997

HGS discloses new cysteine protease inhibitor

Dec. 22, 1997

In vitro and in vivo immunosuppressive effects of FTY-720

Dec. 22, 1997

Peptidomimetic inhibitors of protein farnesyltransferase from Merck & Co.

Dec. 22, 1997

Prevention of neurodegeneration in Parkinson's disease reported

Dec. 22, 1997

Idec's immunotherapy shows promise in phase I/II for non-Hodgkin's lymphoma

Dec. 22, 1997

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
Japan endorses two iPSC drugs for approval under CEA pathway
BioWorld
Japan is backing conditional approvals of Amchepry (raguneprocel, Sumitomo Pharma Co. Ltd./Racthera Co. Ltd.) and Reheart (Cuorips Inc.), positioning them to...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...